heavily in scientific research and development, hoping to promote innovation through technological breakthroughs. China's number of new patents is at the leading level in the world, and the number of research papers has also increased significantly.
However, it is hard to see breakthroughs in basic research and technology in all walks of life. In addition, the possibility of major breakthroughs in areas of fundamental science is relatively small. China is still weak in basic scientific research and technological achievements transformation, and development is beset with difficultiesShenzhen Transpring Enterprise Ltd. is one of and vaporizer (A3 Vape Cartridge etc) manufacturer and supplier in China. Over the years, we have been serving many customers from USA, ... .
There are at least four fundamental reasons for this dilemma:
First of all, the degree of attention is different. China's investment in scientific research has reached about US $200 billion, but only 5% has been used for basic research. In Israel, South Korea, the United States and other countries, basic research accounts for more than 15% of the total R & D investment.
Second, even the best scientific research results need to have the ability to transform technology into commercial value orientation before reaching the market. China's "soft power" is still very immaturePolyU is your best choice - The University offers a variety of undergraduate, taught poly u master's degree and postgraduate research programmes through different faculties and schools, covering business management and finance. .
Third, the tedious regulation will greatly reduce the transformation speed of medical research achievements. For example, the test approval procedures for certain new drug categories can last up to 21 months, and many western countries require less than half the time to approve similar drug trials.
Fourth, China has a great gap in talent. There is still a lack of truly experienced scientists, and it is hard to attract overseas talents to return home.
Some people may see successful cases as high speed rail and wind power as a proof of China's innovation, but these are much of the technology transfer, or the successful application of an engineering solution developed by the foreign side.
China is unlikely to generate engineering breakthroughs in the foreseeable future. Despite the increasing number of engineers in China, they are usually best at all kinds of problems (and their solutions) that are well known. Such talents can bring forth new ideas, but if Limited talents focus on engineering skills for a long time, the progress of innovation will slow down.
It also gives a general explanation of why Chinese carmakers have always been highly dependent on joint venture partners in vehicle platform development, engine technology and other complex system technologies. We may have to wait for many years to see the cars developed by Chinese enterprises.
Where will the future major innovation breakthroughs come from?
Why is medical health?
China has the strength of scientific research.
Beijing's bio pharmaceutical company, Baiji Shenzhou, shows that Chinese enterprises can also achieve excellent results in scientific research and innovation. The company uses speed advantage to focus on accurate positioning. In the last 18 months, four kinds of anticancer drugs have entered clinical trials. Drug development usually involves pre clinical tests, including animal testing, and if successful, it will enter clinical trials again.
Many drugs have failed in the clinical stage. In order to solve this problem, Baiji Shenzhou has built a dedicated experimental model. Baiji Shenzhou has established its own human cancer database, which simulates human trials in preclinical research. This improves the success rate of clinical research and improves the time efficiency of drug development.
Another area of China's innovation is gene sequencing. Shenzhen based Biotech Corp Huada technology has more than 2000 ph.D., and has acquired genetic data from China's huge population. Huada believes that gene sequencing should rely more on computing power and data mining, rather than finding breakthroughs in the laboratory. Huada now controls 50% of the world's genetic sequencing capacity - more than any other scientific research institution.
In American biotechnology companies, senior scientific researchers tend to hold managerial positions (so far away from the front line), and the current level of development in China is still relatively low, so senior researchers will take part in the research work. We should be responsible for the management of large laboratories, but we are immersed in experiments in China.
There are still some problems to be solved in China's health care industry.
The healthcare industry is looking for solutions for some major problems. As consumers' eating habits change, pollution and other environmental problems are aggravated, the incidence of chronic diseases, such as obesity, respiratory diseases, diabetes, cancer and other diseases, will only rise. The scale of chronic diseases in China will far exceed that of other countries and regionsType 1 women increases the risk of adverse outcomes for mother and offspring. Careful preconception counselling and screening is important, with particular focus on glycaemic control, indications for antihypertensive therapy, screening for diabetic nephropathy, diabetic retinopathy and thyroid dysfunction, as well as review of other medications. Supplementation with folic acid should be initiated before conception in order to minimize the risk of fetal malformations. Obtaining and maintaining tight control of blood glucose and blood pressure before and during pregnancy is crucial for optimizing outcomes; .